pentetic acid has been researched along with Disease Exacerbation in 11 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with human epidermal growth factor receptor 2 (HER2) -positive metastatic breast cancer underwent gamma camera imaging from 15 minutes to 7 days after injection of 150 MBq 111In-diethylenetriamine penta-acetic acid anhydride (DTPA) -trastuzumab, after loading-dose trastuzumab, and after once-a-week trastuzumab doses for 11 weeks, and concomitant paclitaxel once every 3 weeks." | 3.73 | Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. ( de Korte, MA; de Vries, EG; Gietema, JA; Jager, PL; Jonkman, S; Kosterink, JG; Lub-De Hooge, MN; Perik, PJ; Sleijfer, DT; van der Graaf, WT; van Veldhuisen, DJ, 2006) |
| "Observation of responses without any toxicity indicates that targeted alpha therapy has the potential to be a safe and effective therapeutic approach for metastatic melanoma." | 2.73 | Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma. ( Abbas Rizvi, SM; Allen, BJ; Apostolidis, C; Bosserhoff, A; Goldsmith, H; Graham, P; Kearsley, J; Morgenstern, A; Raja, C; Reisfeld, R; Song, E; Thompson, J, 2007) |
| "Localization and monitoring of Langerhans cell histiocytosis deposits are based on the combined use of different imaging modalities, which include magnetic resonance, computed tomography, and nuclear medicine procedures." | 2.70 | Functional imaging of Langerhans cell histiocytosis by (111)In-DTPA-D-Phe(1)-octreotide scintigraphy. ( Catalano, L; Lastoria, S; Montella, L; Muto, P; Palmieri, G; Rotoli, B, 2002) |
| "Rats underwent a 1-h middle cerebral artery occlusion followed by reperfusion." | 1.43 | Single photon emission computed tomography imaging of cerebral blood flow, blood-brain barrier disruption, and apoptosis time course after focal cerebral ischemia in rats. ( Bucci, C; Dignat-George, F; Filannino, MA; Garrigue, P; Giacomino, L; Guillet, B; Muzio, V; Pisano, P; Sabatier, F, 2016) |
| "Injury volume during middle cerebral artery occlusion did not predict histological outcome at 2 weeks." | 1.37 | Magnetic resonance imaging (MRI) as a translational tool for the study of neonatal stroke. ( Derugin, N; Dzietko, M; Ferriero, DM; Vexler, ZS; Wendland, M, 2011) |
| "The MR features of pineal cysts, the difficulty of distinguishing benign cysts from cystic neoplasms, and the implications for surgical management are discussed." | 1.29 | A choroid plexus papilloma arising from an incidental pineal cyst. ( McClarty, BM; McGinn, GJ; Steven, DA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garrigue, P | 1 |
| Giacomino, L | 1 |
| Bucci, C | 1 |
| Muzio, V | 1 |
| Filannino, MA | 1 |
| Sabatier, F | 1 |
| Dignat-George, F | 1 |
| Pisano, P | 1 |
| Guillet, B | 1 |
| Kiss, P | 1 |
| Eltoum, IE | 1 |
| Suranyi, P | 1 |
| Zeng, H | 1 |
| Simor, T | 1 |
| Elgavish, A | 1 |
| Elgavish, GA | 1 |
| Dzietko, M | 1 |
| Wendland, M | 1 |
| Derugin, N | 1 |
| Ferriero, DM | 1 |
| Vexler, ZS | 1 |
| Salaun, PY | 1 |
| Campion, L | 1 |
| Bournaud, C | 1 |
| Faivre-Chauvet, A | 1 |
| Vuillez, JP | 1 |
| Taieb, D | 1 |
| Ansquer, C | 1 |
| Rousseau, C | 1 |
| Borson-Chazot, F | 1 |
| Bardet, S | 1 |
| Oudoux, A | 1 |
| Cariou, B | 1 |
| Mirallié, E | 1 |
| Chang, CH | 1 |
| Sharkey, RM | 1 |
| Goldenberg, DM | 1 |
| Chatal, JF | 1 |
| Barbet, J | 1 |
| Kraeber-Bodéré, F | 1 |
| Martin, ME | 1 |
| Moya-Mur, JL | 1 |
| Casanova, M | 1 |
| Crespo-Diez, A | 1 |
| Asin-Cardiel, E | 1 |
| Castro-Beiras, JM | 1 |
| Diez-Jimenez, L | 1 |
| Ballester, M | 1 |
| Carrio, I | 1 |
| Narula, J | 1 |
| Forero, A | 1 |
| Meredith, RF | 1 |
| Khazaeli, MB | 1 |
| Shen, S | 1 |
| Grizzle, WE | 1 |
| Carey, D | 1 |
| Busby, E | 1 |
| LoBuglio, AF | 1 |
| Robert, F | 1 |
| Perik, PJ | 1 |
| Lub-De Hooge, MN | 1 |
| Gietema, JA | 1 |
| van der Graaf, WT | 1 |
| de Korte, MA | 1 |
| Jonkman, S | 1 |
| Kosterink, JG | 1 |
| van Veldhuisen, DJ | 1 |
| Sleijfer, DT | 1 |
| Jager, PL | 1 |
| de Vries, EG | 1 |
| Raja, C | 1 |
| Graham, P | 1 |
| Abbas Rizvi, SM | 1 |
| Song, E | 1 |
| Goldsmith, H | 1 |
| Thompson, J | 1 |
| Bosserhoff, A | 1 |
| Morgenstern, A | 1 |
| Apostolidis, C | 1 |
| Kearsley, J | 1 |
| Reisfeld, R | 1 |
| Allen, BJ | 1 |
| Steven, DA | 1 |
| McGinn, GJ | 1 |
| McClarty, BM | 1 |
| Spuler, S | 1 |
| Yousry, T | 1 |
| Scheller, A | 1 |
| Voltz, R | 1 |
| Holler, E | 1 |
| Hartmann, M | 1 |
| Wick, M | 1 |
| Hohlfeld, R | 1 |
| Lastoria, S | 1 |
| Montella, L | 1 |
| Catalano, L | 1 |
| Rotoli, B | 1 |
| Muto, P | 1 |
| Palmieri, G | 1 |
5 trials available for pentetic acid and Disease Exacerbation
| Article | Year |
|---|---|
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Bispecific; Antibodies, Monoclonal, Humanized; | 2012 |
Role of noninvasive antimyosin imaging in infants and children with clinically suspected myocarditis.
Topics: Adolescent; Child; Child, Preschool; Comorbidity; Disease Progression; Female; Humans; Immunoglobuli | 2004 |
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents | 2005 |
Interim analysis of toxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Biomarkers, Tumor; Co | 2007 |
Functional imaging of Langerhans cell histiocytosis by (111)In-DTPA-D-Phe(1)-octreotide scintigraphy.
Topics: Adult; Diagnosis, Differential; Disease Progression; Female; Histiocytosis, Langerhans-Cell; Humans; | 2002 |
6 other studies available for pentetic acid and Disease Exacerbation
| Article | Year |
|---|---|
Single photon emission computed tomography imaging of cerebral blood flow, blood-brain barrier disruption, and apoptosis time course after focal cerebral ischemia in rats.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain; Brain Ischemia; Cerebrovascular Circulation; Disease | 2016 |
Virtual in vivo biopsy map of early prostate neoplasm in TRAMP mice by MRI.
Topics: Adenocarcinoma; Animals; Biopsy; Contrast Media; Diagnosis, Differential; Disease Models, Animal; Di | 2009 |
Magnetic resonance imaging (MRI) as a translational tool for the study of neonatal stroke.
Topics: Age Factors; Animals; Animals, Newborn; Diffusion Magnetic Resonance Imaging; Disease Models, Animal | 2011 |
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chem | 2006 |
A choroid plexus papilloma arising from an incidental pineal cyst.
Topics: Adult; Brain Diseases; Cell Transformation, Neoplastic; Choroid Plexus Neoplasms; Contrast Media; Cy | 1996 |
Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity.
Topics: Adult; Contrast Media; Disease Progression; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imag | 1996 |